Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
6.97
+0.04 (0.65%)
Nov 17, 2026, 2:34 PM EST - Market open

Envoy Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.230.240.230.320.240.31
Revenue Growth
11.06%7.11%-28.80%33.33%-23.55%-
Gross Profit
-0.63-0.44-0.52-0.47-0.26-0.46
Operating Income
-23.7-22.08-19.26-18.36-8.71-6.87
Net Income
-25.95-28.66-27.97-31.27-15.92-8.68
Earnings Per Share
-3.39-12.32-14.89-25.43-15.73-8.57
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.573.745.484.220.181.12
Total Debt
0.780.9219.660.5634.5423.48
Net Cash (Debt)
13.792.82-14.183.66-34.35-22.36
Net Cash Growth
428.47%-----
Net Cash Per Share
1.801.21-7.552.97-33.93-22.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-22.23-18.2-17.95-17.09-8.81-6.94
Capital Expenditures
-0.21-0.18-0.98-0.15-0.22-0.13
Free Cash Flow
-22.44-18.38-18.93-17.24-9.02-7.06
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-270.56%-183.82%-229.78%-149.68%-110.13%-148.06%
Operating Margin
-10261.04%-9161.83%-8558.22%-5809.81%-3673.42%-2216.45%
Pretax Margin
-9026.41%-9857.26%-9242.22%-9468.99%-6718.57%-2798.39%
Profit Margin
-11233.77%-11892.95%-12432.44%-9895.89%-6718.56%-2798.39%
FCF Margin
-9712.99%-7626.56%-8412.89%-5456.96%-3807.17%-2277.74%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
231.3378.97128.67112.02--